Health and Healthcare

AbbVie : ABBV

All AbbVie Articles

587 Articles

Jon C. Ogg | Sep 3, 2014 at 2:10 PM EDT

Is Infinity Fully Valued Now, or Is More Upside Left?

Infinity Pharmaceuticals will partner with Abbvie to further develop and commercialize IPI-145, also known as Duvelisib.

Lee Jackson | Sep 3, 2014 at 10:45 AM EDT

Credit Suisse’s 4 Top Pharmaceutical Stocks to Buy for the Rest of 2014

A new report from the pharmaceutical team at Credit Suisse highlights four top stocks to buy for the remainder of…

Paul Ausick | Jul 25, 2014 at 8:40 AM EDT

AbbVie Earnings Take Back Seat to Shire Merger

AbbVie reported better-than-expected second-quarter 2014 results before markets opened Friday morning, due in part to strong sales of its Humira…

Jon C. Ogg | Jul 2, 2014 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades: Alcatel-Lucent, Apple, FireEye, JDSU Uniphase, Solar Stocks and More

These are the top analyst upgrades, downgrades and initiations from Wall Street firms for Tuesday, July 2, 2014. They include…

Jon C. Ogg | Jun 2, 2014 at 8:55 AM EDT

Analyst Cancer and Biotech Stock Picks From ASCO

ThinkstockAs the summer starts, a large agenda is out there for investors when it comes to top biotech and specialty…

Trey Thoelcke | May 22, 2014 at 8:20 AM EDT

Why You Buy Big Pharma If the Market Crashes

A new report from the global equity strategy team at Credit Suisse maintains that the best defensive sector now is…

Jon C. Ogg | May 7, 2014 at 8:25 AM EDT

Top Analyst Upgrades and Downgrades: eBay, GNC, Groupon, Hecla, J.C. Penney, Whole Foods and More

These are the top Wall Street analyst upgrades, downgrades and initiations for Wednesday, May 7, 2014. They include eBay, GNC,…

Paul Ausick | May 5, 2014 at 11:20 AM EDT

Why Target Shares Fell Rather Than Rose on CEO Firing

Shares of Target took a hit of around 3% Monday morning following the resignation/firing of CEO Gregg Steinhafel. The interim…

Jon C. Ogg | Mar 27, 2014 at 9:15 AM EDT

Baxter Split-Up, a Page From Abbott’s Playbook

Baxter International is taking an activist investor role of its own. The health care company has announced that it is…

Trey Thoelcke | Mar 14, 2014 at 8:50 AM EDT

Jefferies’ Cheapest Health Care Stocks to Buy

In a new report out from Jefferies, the analysts posted a complete list of the cheapest, on a P/E basis,…

Trey Thoelcke | Mar 4, 2014 at 8:50 AM EST

Merrill Lynch’s Top Health Care Stocks to Buy Now

Merrill Lynch likes the health care sector and has made no secret that they think that it can continue to…

Jon C. Ogg | Feb 8, 2014 at 8:30 AM EST

Five Quantitative Analyst Stocks With Limited Emerging Markets Exposure

In Deutsche Bank's monthly quant view research piece, the firm looks for strategies that investors can implement to limit their…

Jon C. Ogg | Dec 30, 2013 at 11:30 AM EST

Many Key Changes to Goldman Sachs Conviction Buy List for 2014

If one firm can create interest around a stock, it is Goldman Sachs. Investors have followed its Conviction Buy List…

Jon C. Ogg | Dec 7, 2013 at 8:01 AM EST

Goldman Sachs Makes Major Conviction Buy List Changes for 2014

GS.COMIt is that time of year when investors start positioning their portfolios for the year ahead. 24/7 Wall St. reviews…

Jon C. Ogg | Dec 3, 2013 at 8:50 AM EST

Top Analyst Upgrades and Downgrades: Apple, 3D Systems, Micron, Tesla and More

These are the top analyst upgrades, downgrades and initiations from select Wall Street research calls on Tuesday, December 3, 2013.…

1 … 36 37 38 39 40

AbbVie : ABBV

All AbbVie Articles

Is Infinity Fully Valued Now, or Is More Upside Left?

Credit Suisse’s 4 Top Pharmaceutical Stocks to Buy for the Rest of 2014

AbbVie Earnings Take Back Seat to Shire Merger

Top Analyst Upgrades and Downgrades: Alcatel-Lucent, Apple, FireEye, JDSU Uniphase, Solar Stocks and More

Analyst Cancer and Biotech Stock Picks From ASCO

Why You Buy Big Pharma If the Market Crashes

Top Analyst Upgrades and Downgrades: eBay, GNC, Groupon, Hecla, J.C. Penney, Whole Foods and More

Why Target Shares Fell Rather Than Rose on CEO Firing

Baxter Split-Up, a Page From Abbott’s Playbook

Jefferies’ Cheapest Health Care Stocks to Buy

Merrill Lynch’s Top Health Care Stocks to Buy Now

Five Quantitative Analyst Stocks With Limited Emerging Markets Exposure

Many Key Changes to Goldman Sachs Conviction Buy List for 2014

Goldman Sachs Makes Major Conviction Buy List Changes for 2014

Top Analyst Upgrades and Downgrades: Apple, 3D Systems, Micron, Tesla and More

Retiring on a Private Island in the Bahamas is the Dream. Can a $2 Million Nest Egg Make It Happen?

If You Have $10,000 And Want To Bet on AI and Robotics, These Are The Investments I’d Pick

The Lesser-Known Trick That Can Help You Undo a Bad Social Security Filing Decision

Retiring on a Private Island in the Bahamas is the Dream. Can a $2 Million Nest Egg Make It Happen?

The Lesser-Known Trick That Can Help You Undo a Bad Social Security Filing Decision

Retiring on a Private Island in the Bahamas is the Dream. Can a $2 Million Nest Egg Make It Happen?

If You Have $10,000 And Want To Bet on AI and Robotics, These Are The Investments I’d Pick

AbbVie : ABBV

All AbbVie Articles

Is Infinity Fully Valued Now, or Is More Upside Left?

Credit Suisse’s 4 Top Pharmaceutical Stocks to Buy for the Rest of 2014

AbbVie Earnings Take Back Seat to Shire Merger

Top Analyst Upgrades and Downgrades: Alcatel-Lucent, Apple, FireEye, JDSU Uniphase, Solar Stocks and More

Analyst Cancer and Biotech Stock Picks From ASCO

Why You Buy Big Pharma If the Market Crashes

Top Analyst Upgrades and Downgrades: eBay, GNC, Groupon, Hecla, J.C. Penney, Whole Foods and More

Why Target Shares Fell Rather Than Rose on CEO Firing

Baxter Split-Up, a Page From Abbott’s Playbook

Jefferies’ Cheapest Health Care Stocks to Buy

Merrill Lynch’s Top Health Care Stocks to Buy Now

Five Quantitative Analyst Stocks With Limited Emerging Markets Exposure

Many Key Changes to Goldman Sachs Conviction Buy List for 2014

Goldman Sachs Makes Major Conviction Buy List Changes for 2014

Top Analyst Upgrades and Downgrades: Apple, 3D Systems, Micron, Tesla and More

Retiring on a Private Island in the Bahamas is the Dream. Can a $2 Million Nest Egg Make It Happen?

If You Have $10,000 And Want To Bet on AI and Robotics, These Are The Investments I’d Pick

The Lesser-Known Trick That Can Help You Undo a Bad Social Security Filing Decision

Featured Reads

Retiring on a Private Island in the Bahamas is the Dream. Can a $2 Million Nest Egg Make It Happen?

The Lesser-Known Trick That Can Help You Undo a Bad Social Security Filing Decision